ReviewRheumatic diseases clinics of North America2008
Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon.
Review in Rheumatic diseases clinics of North America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 50 citations in OpenAlex.
- G protein estrogen receptor as a potential therapeutic target in Raynaud's phenomenon.Frontiers in pharmacology · 2022Article
- Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.Clinical reviews in allergy & immunology · 2015Observational
- Molecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular traffic.Molecular pharmacology · 2015Article
- Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosis.Scientific reports · 2014Article
- Oxidative damage and antioxidative therapy in systemic sclerosis.Mediators of inflammation · 2014Article
- The pathogenesis, diagnosis and treatment of Raynaud phenomenon.Nature reviews. Rheumatology · 2012Review
- Modulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90.Biochimica et biophysica acta · 2011Article
- Postjunctional α2C-adrenoceptors mediate vasoconstriction in rat tail artery: influence of precontraction and temperature on vasoreactivity.Naunyn-Schmiedeberg's archives of pharmacology · 2010Article
- Local thermal control of the human cutaneous circulation.Journal of applied physiology (Bethesda, Md. : 1985) · 2010Review
- Aging and the control of human skin blood flow.Frontiers in bioscience (Landmark edition) · 2010Article
- Vascular disease in scleroderma.Clinical reviews in allergy & immunology · 2009Review
- Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.International journal of clinical rheumatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Because of the role of the RhoA/Rho kinase (ROCK) pathway in regulating numerous pathologic processes including vasoconstriction, vascular remodeling, and fibrosis, ROCK inhibitors may be especially beneficial in treating Raynaud's phenomenon and scleroderma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.